{"entity":{"type":"insider","cik":"0001276361","url":"/insider/0001276361","json_url":"/insider/0001276361.json","name":"ALTA PARTNERS II INC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":47,"n_filings":20,"first":"2004-02-23","last":"2009-10-20","span_basis":"filed_date"},"name_variants":[{"name":"ALTA PARTNERS II INC","source":"filing","n_filings":20,"first_seen":"2004-02-23","last_seen":"2009-10-20"}],"transactions":[{"id":9266760,"accession":"0001209191-09-049303","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-049303","line_url":"/filing/0001209191-09-049303","is_derivative":false,"issuer_cik":"0001163156","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001163156","owner_cik":null,"owner_name":"ALTA BIOPHARMA MANAGEMENT II LLC; ALTA BIOPHARMA PARTNERS II LP; ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC; ALTA PARTNERS II INC; CHAMPSI FARAH; DELEAGE JEAN","owner_display_name":"ALTA BIOPHARMA MANAGEMENT II LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":349651.0,"shares_display":"349,651","price_per_share":1.38,"price_display":"1.38","price_state":"stated","total_value":482518.38,"total_display":"482,518.38","total_whole":"482,518","shares_owned_after":5484063.0,"shares_owned_after_display":"5,484,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-16","filed_date":"2009-10-20","scope":"insider","n_lines":2},{"id":6043927,"accession":"0001209191-09-049267","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-049267","line_url":"/filing/0001209191-09-049267","is_derivative":false,"issuer_cik":"0001088856","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001088856","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS II LP; CHAMPSI FARAH; ALTA BIOPHARMA MANAGEMENT II LLC; DELEAGE JEAN; ALTA PARTNERS II INC; ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC","owner_display_name":"ALTA BIOPHARMA PARTNERS II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":349651.0,"shares_display":"349,651","price_per_share":1.38,"price_display":"1.38","price_state":"stated","total_value":482518.38,"total_display":"482,518.38","total_whole":"482,518","shares_owned_after":5484063.0,"shares_owned_after_display":"5,484,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-16","filed_date":"2009-10-20","scope":"insider","n_lines":2},{"id":3607657,"accession":"0001209191-08-020303","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-020303","line_url":"/filing/0001209191-08-020303","is_derivative":false,"issuer_cik":"0001077496","issuer_name":"CORCEPT THERAPEUTICS INC","issuer_ticker":"CORT","issuer_name_source":null,"issuer_url":"/issuer/0001077496","owner_cik":null,"owner_name":"ALTA PARTNERS II INC; ALTA CALIFORNIA MANAGEMENT PARTNERS II LLC; DELEAGE JEAN; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS II LP; ALTA EMBARCADERO PARTNERS II LLC","owner_display_name":"ALTA PARTNERS II INC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1059135.0,"shares_display":"1,059,135","price_per_share":2.77,"price_display":"2.77","price_state":"stated","total_value":2933803.95,"total_display":"2,933,803.95","total_whole":"2,933,804","shares_owned_after":5043299.0,"shares_owned_after_display":"5,043,299","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-03-25","filed_date":"2008-03-26","scope":"insider","n_lines":2},{"id":4319461,"accession":"0001209191-06-058251","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-06-058251","line_url":"/filing/0001209191-06-058251#line-2","is_derivative":false,"issuer_cik":"0001106287","issuer_name":"OCCAM NETWORKS INC/DE","issuer_ticker":"OCNW","issuer_name_source":null,"issuer_url":"/issuer/0001106287","owner_cik":null,"owner_name":"GRUENER GARRETT; ALTA CALIFORNIA MANAGEMENT PARTNERS III LLC; JANNEY DANIEL; ALTA PARTNERS II INC; ALTA CALIFORNIA PARTNERS III LP; NOHRA GUY P; ALTA EMBARCADERO PARTNERS III LLC","owner_display_name":"GRUENER GARRETT","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":246000.0,"shares_display":"246,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":1633088.0,"shares_owned_after_display":"1,633,088","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-11-07","filed_date":"2006-11-07","scope":"insider"},{"id":1484170,"accession":"0001209191-05-052704","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-05-052704","line_url":"/filing/0001209191-05-052704","is_derivative":false,"issuer_cik":"0001106287","issuer_name":"COTHERIX INC","issuer_ticker":"CTRX","issuer_name_source":null,"issuer_url":"/issuer/0001106287","owner_cik":null,"owner_name":"GRUENER GARRETT; MARDUEL ALIX; PENHOET EDWARD; NOHRA GUY P; HURWITZ EDWARD; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS III LP; ALTA PARTNERS II INC; DELEAGE JEAN; Alta Partners III, Inc.","owner_display_name":"GRUENER GARRETT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":166937.0,"shares_display":"166,937","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":2170181.0,"total_display":"2,170,181.00","total_whole":"2,170,181","shares_owned_after":869164.0,"shares_owned_after_display":"869,164","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-10-14","filed_date":"2005-10-18","scope":"insider","n_lines":3},{"id":1481826,"accession":"0001209191-05-052406","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-05-052406","line_url":"/filing/0001209191-05-052406","is_derivative":false,"issuer_cik":"0001106287","issuer_name":"COTHERIX INC","issuer_ticker":"CTRX","issuer_name_source":null,"issuer_url":"/issuer/0001106287","owner_cik":null,"owner_name":"HURWITZ EDWARD; ALTA BIOPHARMA PARTNERS III LP; ALTA PARTNERS II INC; MARDUEL ALIX; CHAMPSI FARAH; DELEAGE JEAN; PENHOET EDWARD; GRUENER GARRETT; NOHRA GUY P","owner_display_name":"HURWITZ EDWARD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":247314.0,"shares_display":"247,314","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":3215082.0,"total_display":"3,215,082.00","total_whole":"3,215,082","shares_owned_after":1022064.0,"shares_owned_after_display":"1,022,064","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-10-12","filed_date":"2005-10-14","scope":"insider","n_lines":3},{"id":9258771,"accession":"0001209191-04-049146","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-04-049146","line_url":"/filing/0001209191-04-049146#line-1","is_derivative":false,"issuer_cik":"0001276361","issuer_name":"COTHERIX INC","issuer_ticker":"CTRX","issuer_name_source":null,"issuer_url":"/issuer/0001276361","owner_cik":null,"owner_name":"ALTA PARTNERS II INC; CHAMPSI FARAH; DELEAGE JEAN; GRUENER GARRETT; MARDUEL ALIX; NOHRA GUY P","owner_display_name":"ALTA PARTNERS II INC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":358426.0,"shares_display":"358,426","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":2150556.0,"total_display":"2,150,556.00","total_whole":"2,150,556","shares_owned_after":2363263.0,"shares_owned_after_display":"2,363,263","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-10-15","filed_date":"2004-10-21","scope":"insider"},{"id":630222,"accession":"0001209191-04-048862","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-04-048862","line_url":"/filing/0001209191-04-048862#line-3","is_derivative":false,"issuer_cik":"0001106287","issuer_name":"COTHERIX INC","issuer_ticker":"CTRX","issuer_name_source":null,"issuer_url":"/issuer/0001106287","owner_cik":null,"owner_name":"ALTA PARTNERS II INC; DELEAGE JEAN; NOHRA GUY P; CHAMPSI FARAH; GRUENER GARRETT; MARDUEL ALIX","owner_display_name":"ALTA PARTNERS II INC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":416666.0,"shares_display":"416,666","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":2499996.0,"total_display":"2,499,996.00","total_whole":"2,499,996","shares_owned_after":2421503.0,"shares_owned_after_display":"2,421,503","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-10-15","filed_date":"2004-10-19","scope":"insider"},{"id":251813,"accession":"0001209191-04-024765","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-04-024765","line_url":"/filing/0001209191-04-024765","is_derivative":false,"issuer_cik":"0001034842","issuer_name":"RIGEL PHARMACEUTICALS INC","issuer_ticker":"RIGL","issuer_name_source":null,"issuer_url":"/issuer/0001034842","owner_cik":null,"owner_name":"ALTA BIOPHARMA MANAGEMENT II LLC; ALTA PARTNERS II INC; ALTA BIOPHARMA PARTNERS II LP; CHAMPSI FARAH; MARDUEL ALIX; ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC","owner_display_name":"ALTA BIOPHARMA MANAGEMENT II LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":21.5,"price_display":"21.50","price_state":"stated","total_value":66650.0,"total_display":"66,650.00","total_whole":"66,650","shares_owned_after":352434.0,"shares_owned_after_display":"352,434","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-05-07","filed_date":"2004-05-10","scope":"insider","n_lines":2},{"id":427792,"accession":"0001209191-04-023682","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-04-023682","line_url":"/filing/0001209191-04-023682","is_derivative":false,"issuer_cik":"0001034842","issuer_name":"RIGEL PHARMACEUTICALS INC","issuer_ticker":"RIGL","issuer_name_source":null,"issuer_url":"/issuer/0001034842","owner_cik":null,"owner_name":"MARDUEL ALIX; ALTA BIOPHARMA MANAGEMENT II LLC; ALTA BIOPHARMA PARTNERS II LP; CHAMPSI FARAH; ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC; ALTA PARTNERS II INC","owner_display_name":"MARDUEL ALIX","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":95200.0,"shares_display":"95,200","price_per_share":21.3067,"price_display":"21.31","price_state":"stated","total_value":2028397.84,"total_display":"2,028,397.84","total_whole":"2,028,398","shares_owned_after":355465.0,"shares_owned_after_display":"355,465","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-05-03","filed_date":"2004-05-04","scope":"insider","n_lines":2},{"id":652589,"accession":"0001209191-04-022995","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-04-022995","line_url":"/filing/0001209191-04-022995","is_derivative":false,"issuer_cik":"0001034842","issuer_name":"RIGEL PHARMACEUTICALS INC","issuer_ticker":"RIGL","issuer_name_source":null,"issuer_url":"/issuer/0001034842","owner_cik":null,"owner_name":"CHAMPSI FARAH; MARDUEL ALIX; ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC; ALTA BIOPHARMA PARTNERS II LP; ALTA PARTNERS II INC; ALTA BIOPHARMA MANAGEMENT II LLC","owner_display_name":"CHAMPSI FARAH","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8400.0,"shares_display":"8,400","price_per_share":21.25,"price_display":"21.25","price_state":"stated","total_value":178500.0,"total_display":"178,500.00","total_whole":"178,500","shares_owned_after":448539.0,"shares_owned_after_display":"448,539","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-30","filed_date":"2004-04-30","scope":"insider","n_lines":2},{"id":459444,"accession":"0001209191-04-022845","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-04-022845","line_url":"/filing/0001209191-04-022845","is_derivative":false,"issuer_cik":"0001034842","issuer_name":"RIGEL PHARMACEUTICALS INC","issuer_ticker":"RIGL","issuer_name_source":null,"issuer_url":"/issuer/0001034842","owner_cik":null,"owner_name":"ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC; ALTA BIOPHARMA MANAGEMENT II LLC; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS II LP; MARDUEL ALIX; ALTA PARTNERS II INC","owner_display_name":"ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34800.0,"shares_display":"34,800","price_per_share":21.2504,"price_display":"21.25","price_state":"stated","total_value":739513.92,"total_display":"739,513.92","total_whole":"739,514","shares_owned_after":456751.0,"shares_owned_after_display":"456,751","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-29","filed_date":"2004-04-30","scope":"insider","n_lines":2},{"id":459442,"accession":"0001209191-04-022845","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-04-022845","line_url":"/filing/0001209191-04-022845","is_derivative":false,"issuer_cik":"0001034842","issuer_name":"RIGEL PHARMACEUTICALS INC","issuer_ticker":"RIGL","issuer_name_source":null,"issuer_url":"/issuer/0001034842","owner_cik":null,"owner_name":"ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC; ALTA BIOPHARMA MANAGEMENT II LLC; CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS II LP; MARDUEL ALIX; ALTA PARTNERS II INC","owner_display_name":"ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":21.25,"price_display":"21.25","price_state":"stated","total_value":170000.0,"total_display":"170,000.00","total_whole":"170,000","shares_owned_after":490774.0,"shares_owned_after_display":"490,774","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-28","filed_date":"2004-04-30","scope":"insider","n_lines":2},{"id":591940,"accession":"0001209191-04-022316","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-04-022316","line_url":"/filing/0001209191-04-022316","is_derivative":false,"issuer_cik":"0001034842","issuer_name":"RIGEL PHARMACEUTICALS INC","issuer_ticker":"RIGL","issuer_name_source":null,"issuer_url":"/issuer/0001034842","owner_cik":null,"owner_name":"ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC; MARDUEL ALIX; ALTA BIOPHARMA MANAGEMENT II LLC; ALTA BIOPHARMA PARTNERS II LP; ALTA PARTNERS II INC; CHAMPSI FARAH","owner_display_name":"ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7200.0,"shares_display":"7,200","price_per_share":21.2553,"price_display":"21.26","price_state":"stated","total_value":153038.16,"total_display":"153,038.16","total_whole":"153,038","shares_owned_after":498595.0,"shares_owned_after_display":"498,595","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-27","filed_date":"2004-04-28","scope":"insider","n_lines":2},{"id":591938,"accession":"0001209191-04-022316","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-04-022316","line_url":"/filing/0001209191-04-022316","is_derivative":false,"issuer_cik":"0001034842","issuer_name":"RIGEL PHARMACEUTICALS INC","issuer_ticker":"RIGL","issuer_name_source":null,"issuer_url":"/issuer/0001034842","owner_cik":null,"owner_name":"ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC; MARDUEL ALIX; ALTA BIOPHARMA MANAGEMENT II LLC; ALTA BIOPHARMA PARTNERS II LP; ALTA PARTNERS II INC; CHAMPSI FARAH","owner_display_name":"ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":21.26,"price_display":"21.26","price_state":"stated","total_value":36142.0,"total_display":"36,142.00","total_whole":"36,142","shares_owned_after":505634.0,"shares_owned_after_display":"505,634","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-26","filed_date":"2004-04-28","scope":"insider","n_lines":2},{"id":529151,"accession":"0001209191-04-021816","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-04-021816","line_url":"/filing/0001209191-04-021816","is_derivative":false,"issuer_cik":"0001034842","issuer_name":"RIGEL PHARMACEUTICALS INC","issuer_ticker":"RIGL","issuer_name_source":null,"issuer_url":"/issuer/0001034842","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS II LP; ALTA PARTNERS II INC; MARDUEL ALIX; CHAMPSI FARAH; ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC; ALTA BIOPHARMA MANAGEMENT II LLC","owner_display_name":"ALTA BIOPHARMA PARTNERS II LP","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13100.0,"shares_display":"13,100","price_per_share":21.3195,"price_display":"21.32","price_state":"stated","total_value":279285.45,"total_display":"279,285.45","total_whole":"279,285","shares_owned_after":507296.0,"shares_owned_after_display":"507,296","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-23","filed_date":"2004-04-23","scope":"insider","n_lines":2},{"id":507179,"accession":"0001209191-04-021729","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-04-021729","line_url":"/filing/0001209191-04-021729","is_derivative":false,"issuer_cik":"0001034842","issuer_name":"RIGEL PHARMACEUTICALS INC","issuer_ticker":"RIGL","issuer_name_source":null,"issuer_url":"/issuer/0001034842","owner_cik":null,"owner_name":"ALTA PARTNERS II INC; ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC; CHAMPSI FARAH; MARDUEL ALIX; ALTA BIOPHARMA MANAGEMENT II LLC; ALTA BIOPHARMA PARTNERS II LP","owner_display_name":"ALTA PARTNERS II INC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":21.25,"price_display":"21.25","price_state":"stated","total_value":40375.0,"total_display":"40,375.00","total_whole":"40,375","shares_owned_after":520103.0,"shares_owned_after_display":"520,103","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-22","filed_date":"2004-04-23","scope":"insider","n_lines":2},{"id":507177,"accession":"0001209191-04-021729","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-04-021729","line_url":"/filing/0001209191-04-021729","is_derivative":false,"issuer_cik":"0001034842","issuer_name":"RIGEL PHARMACEUTICALS INC","issuer_ticker":"RIGL","issuer_name_source":null,"issuer_url":"/issuer/0001034842","owner_cik":null,"owner_name":"ALTA PARTNERS II INC; ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC; CHAMPSI FARAH; MARDUEL ALIX; ALTA BIOPHARMA MANAGEMENT II LLC; ALTA BIOPHARMA PARTNERS II LP","owner_display_name":"ALTA PARTNERS II INC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6900.0,"shares_display":"6,900","price_per_share":21.2677,"price_display":"21.27","price_state":"stated","total_value":146747.13,"total_display":"146,747.13","total_whole":"146,747","shares_owned_after":521961.0,"shares_owned_after_display":"521,961","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-21","filed_date":"2004-04-23","scope":"insider","n_lines":2},{"id":528191,"accession":"0001209191-04-020086","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-04-020086","line_url":"/filing/0001209191-04-020086","is_derivative":false,"issuer_cik":"0001034842","issuer_name":"RIGEL PHARMACEUTICALS INC","issuer_ticker":"RIGL","issuer_name_source":null,"issuer_url":"/issuer/0001034842","owner_cik":null,"owner_name":"CHAMPSI FARAH; ALTA BIOPHARMA PARTNERS II LP; ALTA BIOPHARMA MANAGEMENT II LLC; MARDUEL ALIX; ALTA PARTNERS II INC; ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC","owner_display_name":"CHAMPSI FARAH","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60300.0,"shares_display":"60,300","price_per_share":21.0007,"price_display":"21.00","price_state":"stated","total_value":1266342.21,"total_display":"1,266,342.21","total_whole":"1,266,342","shares_owned_after":528707.0,"shares_owned_after_display":"528,707","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-07","filed_date":"2004-04-08","scope":"insider","n_lines":2},{"id":419136,"accession":"0001209191-04-019836","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-04-019836","line_url":"/filing/0001209191-04-019836","is_derivative":false,"issuer_cik":"0001034842","issuer_name":"RIGEL PHARMACEUTICALS INC","issuer_ticker":"RIGL","issuer_name_source":null,"issuer_url":"/issuer/0001034842","owner_cik":null,"owner_name":"ALTA BIOPHARMA MANAGEMENT II LLC; ALTA PARTNERS II INC; CHAMPSI FARAH; MARDUEL ALIX; ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC; ALTA BIOPHARMA PARTNERS II LP","owner_display_name":"ALTA BIOPHARMA MANAGEMENT II LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9700.0,"shares_display":"9,700","price_per_share":21.0,"price_display":"21.00","price_state":"stated","total_value":203700.0,"total_display":"203,700.00","total_whole":"203,700","shares_owned_after":587660.0,"shares_owned_after_display":"587,660","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-06","filed_date":"2004-04-07","scope":"insider","n_lines":2},{"id":419134,"accession":"0001209191-04-019836","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-04-019836","line_url":"/filing/0001209191-04-019836","is_derivative":false,"issuer_cik":"0001034842","issuer_name":"RIGEL PHARMACEUTICALS INC","issuer_ticker":"RIGL","issuer_name_source":null,"issuer_url":"/issuer/0001034842","owner_cik":null,"owner_name":"ALTA BIOPHARMA MANAGEMENT II LLC; ALTA PARTNERS II INC; CHAMPSI FARAH; MARDUEL ALIX; ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC; ALTA BIOPHARMA PARTNERS II LP","owner_display_name":"ALTA BIOPHARMA MANAGEMENT II LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":22.95,"price_display":"22.95","price_state":"stated","total_value":27540.0,"total_display":"27,540.00","total_whole":"27,540","shares_owned_after":597143.0,"shares_owned_after_display":"597,143","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-05","filed_date":"2004-04-07","scope":"insider","n_lines":2},{"id":623928,"accession":"0001209191-04-017682","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-04-017682","line_url":"/filing/0001209191-04-017682","is_derivative":false,"issuer_cik":"0001034842","issuer_name":"RIGEL PHARMACEUTICALS INC","issuer_ticker":"RIGL","issuer_name_source":null,"issuer_url":"/issuer/0001034842","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS II LP; ALTA BIOPHARMA MANAGEMENT II LLC; MARDUEL ALIX; ALTA PARTNERS II INC; CHAMPSI FARAH; ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC","owner_display_name":"ALTA BIOPHARMA PARTNERS II LP","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7487.0,"shares_display":"7,487","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":149740.0,"total_display":"149,740.00","total_whole":"149,740","shares_owned_after":598316.0,"shares_owned_after_display":"598,316","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-03-24","filed_date":"2004-03-26","scope":"insider","n_lines":2},{"id":9258278,"accession":"0001209191-04-017676","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-04-017676","line_url":"/filing/0001209191-04-017676","is_derivative":false,"issuer_cik":"0001034842","issuer_name":"RIGEL PHARMACEUTICALS INC","issuer_ticker":"RIGL","issuer_name_source":null,"issuer_url":"/issuer/0001034842","owner_cik":null,"owner_name":"ALTA BIOPHARMA MANAGEMENT II LLC; ALTA BIOPHARMA PARTNERS II LP; ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC; ALTA PARTNERS II INC; CHAMPSI FARAH; MARDUEL ALIX","owner_display_name":"ALTA BIOPHARMA MANAGEMENT II LLC","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":74464.0,"shares_display":"74,464","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":1489280.0,"total_display":"1,489,280.00","total_whole":"1,489,280","shares_owned_after":13835.0,"shares_owned_after_display":"13,835","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-02-19","filed_date":"2004-03-26","scope":"insider","n_lines":2},{"id":649267,"accession":"0001209191-04-012112","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-04-012112","line_url":"/filing/0001209191-04-012112","is_derivative":false,"issuer_cik":"0001034842","issuer_name":"RIGEL PHARMACEUTICALS INC","issuer_ticker":"RIGL","issuer_name_source":null,"issuer_url":"/issuer/0001034842","owner_cik":null,"owner_name":"ALTA BIOPHARMA PARTNERS II LP; ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC; CHAMPSI FARAH; MARDUEL ALIX; ALTA BIOPHARMA MANAGEMENT II LLC; ALTA PARTNERS II INC","owner_display_name":"ALTA BIOPHARMA PARTNERS II LP","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":111696.0,"shares_display":"111,696","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":2233920.0,"total_display":"2,233,920.00","total_whole":"2,233,920","shares_owned_after":569236.0,"shares_owned_after_display":"569,236","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-02-19","filed_date":"2004-02-23","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001088856","name":"CORCEPT THERAPEUTICS INC","url":"/issuer/0001088856","role":"Ten percent owner","n_filings":3,"first_seen":"2008-03-26","last_seen":"2009-10-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001108185","name":"OCCAM NETWORKS INC/DE","url":"/issuer/0001108185","role":"Other","n_filings":1,"first_seen":"2006-11-07","last_seen":"2006-11-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001138812","name":"COTHERIX INC","url":"/issuer/0001138812","role":"Ten percent owner","n_filings":4,"first_seen":"2004-10-19","last_seen":"2005-10-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001034842","name":"RIGEL PHARMACEUTICALS INC","url":"/issuer/0001034842","role":"Ten percent owner","n_filings":12,"first_seen":"2004-02-23","last_seen":"2004-05-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001276361","retrieved_at":"2026-08-23T09:20:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}